Carretta Angelo, Casiraghi Monica, Melloni Giulio, Bandiera Alessandro, Ciriaco Paola, Ferla Luca, Puglisi Armando, Zannini Piero
Department of Thoracic Surgery, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.
Eur J Cardiothorac Surg. 2009 Aug;36(2):352-6; discussion 356. doi: 10.1016/j.ejcts.2009.02.049. Epub 2009 Apr 11.
Although surgery remains the gold standard for the treatment of benign tracheal stenosis, airway stenting may be indicated in the event of complex lesions or associated diseases. We retrospectively investigated Montgomery T-tube placement as an alternative or complementary treatment to surgery.
From January 1984 to March 2008, 158 patients were treated for benign tracheal lesions. Eighty-three patients underwent airway resection and reconstruction as the only treatment. Seventy-five other patients with complex lesions or major associated diseases were treated with a T-tube and were retrospectively analysed. Seven of them had undergone unsuccessful treatment with Dumon stents. T-tube placement was the only procedure adopted in 51 patients with a contraindication to surgery (group I), a temporary measure in 15 patients prior to surgery (group II), and in 9 patients (group III) for complications of airway reconstruction, 5 of whom were referred from other institutions.
Complications after T-tube placement were: stent dislocation in 3 (4%) patients, endoluminal granulomas in 14 (19%), subglottic edema in 3 (4%), and sputum retention in 7 (9%). Treatment of complications (tracheostomy cannula, steroid infiltration, Argon/LASER coagulation, and bronchoscopy) was required in 20 (27%) patients. In group I, the tube was removed in 12 (24%) patients after 35.3 +/- 8.2 months following resolution of the stenosis. In group II, the tubes were maintained in place before surgery for 17.1 +/- 4.8 months. In group III, three stents were removed following tracheal healing after 115.3 +/- 3.7 months. After 5 years the stents were in place in 82%, 7% and 100% of the patients, respectively in groups I, II and III.
Montgomery T-tube placement represents a useful option in patients with complex benign tracheal stenosis or associated diseases as an alternative or complementary treatment to surgery, and is effective even when other types of stents are unsuccessful.
尽管手术仍然是治疗良性气管狭窄的金标准,但在病变复杂或伴有相关疾病的情况下,气道支架置入术可能是一种选择。我们回顾性研究了蒙哥马利T形管置入术作为手术的替代或补充治疗方法。
1984年1月至2008年3月,158例患者接受了良性气管病变治疗。83例患者仅接受了气道切除和重建治疗。另外75例病变复杂或伴有主要相关疾病的患者接受了T形管治疗,并进行了回顾性分析。其中7例患者使用杜蒙支架治疗失败。51例有手术禁忌证的患者仅采用了T形管置入术(I组),15例患者在手术前采用T形管作为临时措施(II组),9例因气道重建并发症而采用T形管的患者(III组),其中5例来自其他机构转诊。
T形管置入术后的并发症有:3例(4%)患者支架移位,14例(19%)患者腔内肉芽肿,3例(4%)患者声门下水肿,7例(9%)患者痰液潴留。20例(27%)患者需要对并发症进行治疗(气管切开套管、类固醇浸润、氩/激光凝固和支气管镜检查)。I组中,12例(24%)患者在狭窄解除后35.3±8.2个月拔除了T形管。II组中,T形管在手术前保留了17.1±4.8个月之久。III组中,3例支架在气管愈合后115.3±3.7个月拔除。5年后,I组、II组和III组分别有82%、7%和100%的患者仍保留着支架。
蒙哥马利T形管置入术对于患有复杂良性气管狭窄或相关疾病的患者来说,是一种有用的选择,可作为手术的替代或补充治疗方法,即使在其他类型支架治疗失败时也有效。